The role of cervicovaginal microbiota in the occurrence of severe cervical intraepithelial dysplasia

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Despite the availability of visual examination of the cervix, cervical screening in Russia has not been widespread enough, and therefore the incidence of cervical cancer remains consistently high. In recent years, the vaginal microbiota is given special attention as a risk factor for the development of precancerous diseases of the cervix.

AIM: The aim of this study was to compare the cervicovaginal microbiota in patients with high-grade squamous intraepithelial lesions (HSIL) or negative for intraepithelial lesions or malignancy (NILM).

MATERIALS AND METHODS: Microorganisms isolated from the cervicovaginal microbiota were identified in 40 patients using the mass spectrometry method. 20 women had severe cervical dysplasia, and the other 20 were healthy women without precancerous cervical lesions.

RESULTS: Corynebacterium spp. and Streptococcus spp. were found more often in the cervicovaginal microbiome in patients with high-grade squamous intraepithelial lesions than in women negative for intraepithelial lesions or malignancy.

CONCLUSIONS: The data obtained suggest that the presence of Corynebacterium spp. and Streptococcus spp. in the cervicovaginal microbiota is associated with the presence of severe cervical intraepithelial changes.

Full Text

BACKGROUND

According to the World Health Organization, cervical cancer (CC) is the fourth most prevalent cancer among oncological pathologies and constitutes a significant threat to women’s reproductive health and life [1, 2]. In 2021, CC was identified in 126.7 observations per 100 thousand population in Russia [3]. The early diagnosis of cervical precancerous lesions is crucial, as it significantly reduces CC incidence [4].

The human papillomavirus (HPV) is the most significant etiologic factor of cervical intraepithelial neoplasia (CIN) and CC [5–7]. In approximately 80%–90% of cases, the papillomavirus infection is spontaneously eliminated. However, in 10%–20% of cases, HPV persists and increases CIN and CC risk [8]. Several contributing factors to the persistence of HPV have been identified, including smoking, HIV infection, autoimmune diseases, age, and cervicovaginal microbiota disruption [9]. Consequently, microbial imbalance affects female reproductive health, susceptibility to infections, and the course of various infections, including sexually transmitted infections, such as HPV [10]. There is increasing evidence on the effect of chronic cervicitis on the course and progression of CIN.

Advances in medical microbiology in the previous years have enabled the assessment of the vaginal microbiota. In 2011, a new classification of vaginal community types was proposed and was supplemented in 2020 [11]. Several studies of the vaginal microbiome are based on this classification, and CIN severity is correlated with an increase in the number of vaginal community types [12]. The vagina is typically populated by bacteria of the genus Lactobacillus, which produce an acidic reaction in vaginal fluid. This fluid contains various biologically active substances that protect against infection and overgrowth of pathogens. Numerous studies have demonstrated a correlation between reduced Lactobacillus levels and high bacterial diversity and the presence of HPV, CIN, and CC [10, 13].

This study aimed to compare the cervicovaginal microbiota in patients with high-grade squamous intraepithelial lesions (HSIL) to that in patients without cervical precancerous lesions (negative for intraepithelial lesion or malignancy, NILM).

MATERIALS AND METHODS

A prospective study was conducted at the Department of Obstetrics and Gynecology of Samara State Medical University from November 2021 to April 2022. Forty women of reproductive age (18–45 years) were enrolled and divided into two groups. The study group included 20 patients with HSIL, with a mean age of 36 ± 5.7 years, and the control group consisted of 20 women with NILM and abnormal colposcopic findings, with a mean age of 35 ± 6.7 years.

The inclusion criteria were HSIL diagnosed by cytologic examination, presence of high-risk HPV, and signed informed consent to participate in the study.

Conversely, the exclusion criteria included pregnancy, HIV infection, hepatitis B or C, autoimmune disease, use of antibiotics within 15 days prior to specimen collection, sexual intercourse, or menstruation within 48 h prior to specimen collection.

The participants underwent sterile swab collection of native material from the cervical canal for culture on nutrient medium and subsequent culture studies. Extended colposcopy and targeted cervical biopsy were performed under visualization using a portable digital colposcope (patent pending, 2023127147). The biopsy specimens were placed in Ames liquid transport medium and transported to the laboratory for 2 h under isothermal conditions for microbiological examination. Then, electro-radio-surgical high-frequency cervical conization or pinpoint targeted biopsy and cervical scraping were conducted. The obtained material was sent for histological examination.

In the laboratory, the material was sown on an expanded set of dense nutrient media, including 5% blood agar; anaerobic agar; agars for the isolation of Veillonella, clostridia, bifidobacteria, and lactobacilli (all agars produced by HiMedia, India); and universal chromogenic medium (Bio-Rad, USA). The cultures were incubated for 5 days under aerobic and anaerobic conditions. Thereafter, all isolated microorganisms were identified by time-of-flight mass spectrometry with matrix-assisted laser desorption/ionization (Microflex LT, Bruker).

The species and quantitative composition of microbiota in cervical smears and cervical biopsy and association with cervical intraepithelial changes were evaluated.

Statistical analysis was conducted using the StatTech 3.1.8 software. Correlations were evaluated using Pearson’s χ2 criterion, Fisher’s exact test, Mann–Whitney U-criterion, and Student’s t-criterion. P < 0.05 indicated significant differences.

RESULTS

A microbiological evaluation revealed that Streptococcus spp. were 3.7 times more prevalent in women with severe cervical intraepithelial dysplasia than in those without precancerous cervical lesions. The odds differences were significant (95% confidence interval (CI): 1.420–9.470; p = 0.027; Fig. 1). The number of streptococci in patients with CIN in the culture and biopsy were similar (95% CI: 0.288–3.476). These results indirectly indicate the role of streptococci in dysplastic processes in the cervix.

 

Fig. 1. Presence of Streptococcus spp. depending on the presence and absence of cervical dysplasia in culture from the cervical canal and biopsy

Рис. 1. Наличие Streptococcus spp. в зависимости от наличия и отсутствия дисплазии шейки матки в посеве из цервикального канала и биоптате

 

The predominant species within the Streptococcus genus was Streptococcus anginosus, which constituted most of the streptococcal species within the main group. They are part of the oropharyngeal microflora along with Streptococcus oralis, Streptococcus mitis, and Streptococcus sanguinis and are associated with oral cavity diseases (Table 1). The role of these microorganisms in the development of genital pathology remains poorly understood. The prevalence of unprotected oral–genital contact may be a contributing factor to the occurrence of these bacteria in the vaginal microflora. The results and literature data indicate that the presence of Streptococcus spp. is associated with the presence of severe cervical intraepithelial lesions.

 

Table 1. Species composition of Streptococcus spp. in the study groups

Таблица 1. Видовой состав Streptococcus spp. в группах

Streptococcus spp. species

Cervical biopsy

Cervical canal

Comparison group, n

Study group, n

Comparison group, n

Study group, n

S. vestibularis

1

1

S. oralis

1

3

1

S.anginosus

2

8

4

8

S. mitis

1

1

S. sanguinis

1

S. pseudopneumonia

1

S. galloliticus

1

S.agalactiae

1

3

2

S. parasanguinis

1

S. salivarius

1

S. pneumonia

1

 

Furthermore, significant differences were observed in Corynebacterium spp. between the groups. In patients with HSIL, Corynebacterium spp. were isolated at a frequency that was 2.8 times higher than that in the comparison group (95% CI: 1.137–7.152; p = 0.002; Fig. 2).

 

Fig. 2. Presence of Corynebacterium spp. depending on the presence and absence of cervical dysplasia in culture from the cervical canal and biopsy

Рис. 2. Наличие Corynebacterium spp. в зависимости от наличия и отсутствия дисплазии шейки матки в посеве из цервикального канала и биоптате

 

These bacteria can adhere to vaginal and cervical epithelial cells, bind to intercellular matrix proteins, and stimulate cytokine production. This allows these bacteria to compete with other microorganisms for adhesion sites and exist in the vaginal microflora in normal and dysbiosis [14]. Data indicate that Corynebacterium spp. retains its ability to invade, as 5.6 times more bacteria of this genus were isolated from the cervical biopsy than from the culture. The differences in odds were significant (95% CI: 1.420–21.860; p = 0.025). Table 2 presents the species composition of Corynebacterium spp.

 

Table 2. Species composition of Corynebacterium spp. in the study groups

Таблица 2. Видовой состав Corynebacterium spp. в группах

Corynebacterium spp. species

Cervical biopsy (number of patients)

Cervical canal (number of patients)

Comparison group, n

Study group, n

Comparison group, n

Study group, n

C. aurumucosum

4

5

5

6

C. amylocatum

3

5

4

2

C. tuberculostearicum

3

3

1

2

C. simulans

1

2

C. pyruviciproducens

1

C. mucifaciens

1

C. coyleae

1

1

1

C. riegelii

1

C. accolens

1

C. sundsvallense

1

C. minutissimum

2

 

A statistical analysis (using the Mann–Whitney U-criterion) was conducted to compare the patients based on their age of sexual debut. The mean age of sexual debut was 16 (15–18) years in the study group and 18 (17–18) years in the comparison group (p = 0.010).

The body mass index of the women was greater in the study group [26 ± 5 (95% CI: 24–29) vs. 23 ± 3 (95% CI: 21–25) kg/m2 in the comparison group; p = 0.030], with an average that was higher than normal.

In the present study, no significant differences were found in smoking rates between the two groups (p = 0.054).

DISCUSSION

The results indicate significant differences in cervicovaginal microbiome, age of sexual debut, and body mass index between the groups.

In a study by Chen et al. on patients with HSIL, the Streptococcaceae and Prevotellaceae families of bacteria were found to be the most prevalent, and the severity of CIN correlated with the number of different types of vaginal communities [13]. Kang et al. revealed the role of Streptococcus in the occurrence of CIN and СС and indicated that the activation of multiple pro-inflammatory cytokines, including interleukin-17, produced in response to streptococcal colonization, affects vaginal and cervical epithelial cells. Moreover, Soares et al. demonstrated that streptococci possess metallopeptidases capable of cleaving extracellular matrix proteins, including fibronectin, laminin, type IV collagen, fibrinogen, and albumin. This process facilitates their penetration into tissues and contributes to bacterial dissemination [15, 16].

The role of corynebacteria in the vaginal microbiome remains unclear. In a study by Manzanares-Leal et al., Corynebacterium spp. and Staphylococcus spp. were found to be the predominant bacteria in women with СС [17]. In contrast, Gladysheva et al. observed a beneficial effect of Corynebacterium amycolatum on the microflora [18]. This underscores the need for further investigation in this field.

The results obtained are comparable with those of other studies in that early initiation of sexual activity is a risk factor for CIN. A meta-analysis of 10 studies involving 6,492 individuals revealed that the earlier women initiated sexual activity, the greater the risk of developing СС [20].

Notably, obesity represents a risk factor for cancer of various localizations. Furthermore, excess body weight has been demonstrated to influence CC progression [22]. Nevertheless, in a case-control study involving 188 women, Ssedyabane et al. found no significant differences in the occurrence of severe dysplasia depending on obesity [23].

A substantial corpus of literature exists on the increased cancer risk associated with smoking. A meta-analysis of 45 studies conducted by Nagelhout et al. showed that smoking plays a role in the development of precancerous lesions and CC [24].

The data on the influence of age on cervical dysplasia onset and progression is inconclusive. Thus, in a study by Zhdan et al. including 120 women (group 1, 40 women with CC; group 2, 80 women without CC), the age of 40 years or above was found to increase the risk of СС by a factor of 14 [25]. Furthermore, in a study involving 314,587 patients, Xiao et al. found no correlation between age and CIN occurrence [26].

CONCLUSIONS

Therefore, the state of the cervicovaginal microflora, age of sexual debut, and body mass index may influence the occurrence of cervical intraepithelial dysplasia of severe malignancy. The study group exhibited a higher prevalence of Streptococcus spp. and Corynebacterium spp. in their cervicovaginal microflora, which supports the hypothesis that these species play a role in the development of CIN. No correlation was observed between the other detected microorganisms and cervical intraepithelial changes. The microbiota showed qualitative and quantitative differences between cervical biopsy and cervical smear samples. The occurrence of HSIL was influenced by earlier age of sexual debut and being overweight, whereas smoking induced no effect. The findings underscore the need for further research in this field.

ADDITIONAL INFORMATION

Funding source. The study has been supported by Gubernskii Grant No. 352 of 31.07.2023.

Competing interests. The authors declare that there is no potential conflict of interest requiring disclosure in this article.

Author contribution. All the authors have made a significant contribution to the development of the concept, research, and preparation of the article as well as read and approved the final version before its publication.

Personal contribution of the authors: E.F. Kira — study concept and design, editing; A.V. Kazakova, S.M. Chechko — study concept and design, collection and processing of material, text writing.

Ethics approval. The present study protocol was approved by the local Ethics Committee of the Samara State Medical University (No. 217 dated 10.02.2021).

ДОПОЛНИТЕЛЬНАЯ ИНФОРМАЦИЯ

Источник финансирования. Исследование было поддержано Губернским грантом № 352 от 31.07.2023.

Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.

Вклад авторов. Все авторы внесли существенный вклад в разработку концепции, проведение исследования и подготовку статьи, прочли и одобрили финальную версию перед публикацией.

Наибольший вклад распределен следующим образом: Е.Ф. Кира — концепция и дизайн исследования, редактирование; А.В. Казакова, С.М. Чечко — концепция и дизайн исследования, сбор и обработка материала, написание текста.

Этический комитет. Протокол исследования был одобрен локальным этическим комитетом Самарского государственного медицинского университета (№ 217 от 10.02.2021).

×

About the authors

Anna V. Kazakova

Samara State Medical University

Email: amigo14021980@yandex.ru
ORCID iD: 0000-0002-9483-8909
SPIN-code: 5129-5915

MD, Dr. Sci. (Med.), Assistant Professor

Russian Federation, Samara

Svetlana M. Chechko

Samara State Medical University

Author for correspondence.
Email: svetlana-chechko@mail.ru
ORCID iD: 0000-0002-3890-9944
SPIN-code: 1069-5588
Russian Federation, Samara

Evgeny F. Kira

Medical Academy, MEDSI Group of Companies

Email: profkira33@gmail.com
ORCID iD: 0000-0002-1376-7361
SPIN-code: 8955-9775

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

References

  1. World Health Organization [Internet]. Screening and treatment recommendations to prevent cervical cancer. Available from: https://www.who.int/news/item/06-07-2021-new-recommendations-for-screening-and-treatment-to-prevent-cervical-cancer [cited 2023 Sept 26.09].
  2. Rajaram S., Gupta B. Screening for cervical cancer: choices and dilemmas. Indian J Med Res. 2021;154(2):210–220. doi: 10.4103/ijmr.IJMR_857_20
  3. Kaprin AD, Starinskogo VV, Shaxzadovoĭ AO, editors. The state of cancer care for the population of Russia in 2021. Moscow: MNIOI im. P.A. Herzen – branch of the Federal State Budgetary Institution “National Medical Research Center of Radiology” of the Ministry of Health of Russia, 2022. (In Russ.)
  4. Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol. 2019;71(4):313–320. doi: 10.23736/S0026-4784.19.04397-1
  5. Shmakova NA, Chistyakova GN, Kononova IN, et al. High oncogenic risk of cervical intraepithelial neoplasia and cervical cancer: the urgency of the problem, the search for prospects (literature review). Russian Journal of Human Reproduction. 2021;27(1):33-38. EDN: BGTJGG doi: 10.17116/repro20212701133
  6. Abakarova PR, Prilepskaya VN, Mezhevitinova EA, et al. Local cytokine therapy in a comprehensive treatment of HPV-associated cervical diseases. Gynecology. 2019;21(1):28–32. EDN: VYEBDU doi: 10.26442/20795696.2019.1.190284
  7. Cohen PA, Jhingran A, Oaknin A, et. al. Cervical cancer. Lancet. 2019;393(10167):169–182. doi: 10.1016/S0140-6736(18)32470-X
  8. Prilepskaya VN. HPV-associated cervical diseases: screening, methods of examination, principles of treatment. Gynecology. 2019;21(3):6–8. EDN: PRNMJI doi: 10.26442/20795696.2019.3.190595
  9. Aballéa S, Beck E, Cheng X, et al. Risk factors for cervical cancer in women in China: a meta-model. Womens Health. 2020;16. doi: 10.1177/1745506520940875
  10. Kira EF. Bacterial vaginosis. Moscow: MIA, 2012. (In Russ.) EDN: SZPGYL
  11. Borgogna JC, Shardell MD, Santori EK, et al. The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis. BJOG. 2020;127(2):182–192. doi: 10.1111/1471-0528.15981
  12. Smith BC, McAndrew T, Chen Z, et al. The cervical microbiome over 7 years and a comparison of methodologies for its characterization. PLoS One. 2012;7(7). doi: 10.1371/journal.pone.0040425
  13. Chen Y, Qiu X, Wang W, et al. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort. BMC Infect Dis. 2020;20(1):629. doi: 10.1186/s12879-020-05324-9
  14. Gladysheva IV, Cherkasov SV. Corinebacteria of vaginal microbiom – potential pathogens or perspective probiotcs? Bulletin of the Orenburg Scientific Center of the Ural Branch of the Russian Academy of Sciences. 2019;(3):17. Available from: http://elmag.uran.ru:9673/magazine/Numbers/2019-3/Articles/GIV-2019-3.pdf. EDN: XRPVSW doi: 10.24411/2304-9081-2019-13022
  15. Soares GC, da Silva BA, Dos Santos MH, et al. Metallopeptidases produced by group B Streptococcus: influence of proteolytic inhibitors on growth and on interaction with human cell lineages. Int J Mol Med. 2008;22(1):119–125.
  16. Kang GU, Jung DR, Lee YH, et al. Potential association between vaginal microbiota and cervical carcinogenesis in korean women: a cohort study. Microorganisms. 2021;9(2):294. doi: 10.3390/microorganisms9020294
  17. Manzanares-Leal GL, Coronel-Martínez JA, Rodríguez-Morales M, et al. Preliminary Identification of the aerobic cervicovaginal microbiota in Mexican women with cervical cancer as the first step towards metagenomic studies. Front Cell Infect Microbiol. 2022;12. doi: 10.3389/fcimb.2022.838491
  18. Gladysheva IV, Chertkov KL, Cherkasov SV, et al. Probiotic potential, safety properties, and antifungal activities of corynebacterium amycolatum ICIS 9 and corynebacterium amycolatum ICIS 53 strains. Probiotics Antimicrob Proteins. 2023;15(3):588–600. doi: 10.1007/s12602-021-09876-3
  19. Makuza JD, Nsanzimana S, Muhimpundu MA, et al. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22:26. doi: 10.11604/pamj.2015.22.26.7116
  20. Mekonnen AG, Mittiku YM. Early-onset of sexual activity as a potential risk of cervical cancer in Africa: a review of literature. PLOS global public health. 2023;3(3). doi: 10.1371/journal.pgph.0000941
  21. Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121–135. doi: 10.1016/j.metabol.2018.11.001
  22. Gnade CM, Hill EK, Botkin HE, et al. Effect of obesity on cervical cancer screening and outcomes. J Low Genit Tract Dis. 2020;24(4):358–362. doi: 10.1097/LGT.0000000000000570
  23. Ssedyabane F, Ngonzi J, Kajabwangu R, et al. Association between obesity and cervical intraepithelial neoplasia: results from a case control study in south western Uganda. BMC Women’s Health. 2023;23(1):159. doi: 10.1186/s12905-023-02315-1
  24. Nagelhout G, Ebisch RM, Van Der Hel O, et al. Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis. Expert Rev Anticancer Ther. 2021;21(7):781–794. doi: 10.1080/14737140.2021.1888719
  25. Zhdan VM, Holovanova IA, Vovk OY, et al. relationship between cervical cancer and the level of preventive oncological examinations. Wiad Lek. 2021;74(6):1428–1432.
  26. Xiao T, Ou CQ, Yang J, et al. The Risk Factors for cervical cytological abnormalities among women infected with non-16/18 high-risk human papillomavirus: cross-sectional study. JMIR Public Health Surveill. 2022;8(12). doi: 10.2196/38628

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Presence of Streptococcus spp. depending on the presence and absence of cervical dysplasia in culture from the cervical canal and biopsy

Download (128KB)
3. Fig. 2. Presence of Corynebacterium spp. depending on the presence and absence of cervical dysplasia in culture from the cervical canal and biopsy

Download (133KB)

Copyright (c) 2024 Eсо-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies